Metamol Theranostics
A NEW Test to Determine Breast Cancer Risk.A Breakthrough! Women with lumps in their breasts have to make a difficult decision whether or not to undergo treatment. For these women, a NEW TEST can help in the assessment of their cancer risk and hugely facilitate their decision-making process. We have studied a protein (called hOPN-c), which serves this purpose. The presence of hOPN-c in a lump indicates an elevated risk for breast cancer down the road, and the more of it is detected the more substantive is the risk. A pathologist can simply apply this test to a biopsy
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Metamol Theranostics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 1 contacts at Metamol Theranostics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Metamol Theranostics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.